KR20220041492A - Enzyme Preparation comprising Dietary Fiber - Google Patents
Enzyme Preparation comprising Dietary Fiber Download PDFInfo
- Publication number
- KR20220041492A KR20220041492A KR1020200124771A KR20200124771A KR20220041492A KR 20220041492 A KR20220041492 A KR 20220041492A KR 1020200124771 A KR1020200124771 A KR 1020200124771A KR 20200124771 A KR20200124771 A KR 20200124771A KR 20220041492 A KR20220041492 A KR 20220041492A
- Authority
- KR
- South Korea
- Prior art keywords
- enzyme preparation
- dietary fiber
- enzyme
- powder
- present
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 59
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 27
- 230000001737 promoting effect Effects 0.000 claims abstract description 8
- 230000004060 metabolic process Effects 0.000 claims abstract description 5
- 235000013376 functional food Nutrition 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 20
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 11
- 240000007594 Oryza sativa Species 0.000 claims description 10
- 235000007164 Oryza sativa Nutrition 0.000 claims description 10
- 235000009566 rice Nutrition 0.000 claims description 10
- 235000013339 cereals Nutrition 0.000 claims description 8
- 241001116389 Aloe Species 0.000 claims description 7
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 7
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 7
- 229920002752 Konjac Polymers 0.000 claims description 7
- 235000011399 aloe vera Nutrition 0.000 claims description 7
- 230000029087 digestion Effects 0.000 claims description 7
- 239000000252 konjac Substances 0.000 claims description 7
- 235000010485 konjac Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 5
- 235000000885 Garcinia xanthochymus Nutrition 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 5
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 244000119461 Garcinia xanthochymus Species 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 208000004880 Polyuria Diseases 0.000 claims description 3
- 229940119217 chamomile extract Drugs 0.000 claims description 3
- 235000020221 chamomile extract Nutrition 0.000 claims description 3
- 230000035619 diuresis Effects 0.000 claims description 3
- 230000011132 hemopoiesis Effects 0.000 claims description 3
- 230000036039 immunity Effects 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 2
- 239000004382 Amylase Substances 0.000 abstract description 13
- 108010065511 Amylases Proteins 0.000 abstract description 13
- 102000013142 Amylases Human genes 0.000 abstract description 13
- 108091005804 Peptidases Proteins 0.000 abstract description 13
- 235000019418 amylase Nutrition 0.000 abstract description 13
- 230000006870 function Effects 0.000 abstract description 13
- 239000004365 Protease Substances 0.000 abstract description 11
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 10
- 230000001079 digestive effect Effects 0.000 abstract description 4
- 230000009088 enzymatic function Effects 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 47
- 230000000694 effects Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 240000005979 Hordeum vulgare Species 0.000 description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010034568 Peripheral coldness Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229920002581 Glucomannan Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 244000134552 Plantago ovata Species 0.000 description 3
- 235000003421 Plantago ovata Nutrition 0.000 description 3
- 239000009223 Psyllium Substances 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229940089491 hydroxycitric acid Drugs 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 229940070687 psyllium Drugs 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000593508 Garcinia Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 244000134540 Polymnia sonchifolia Species 0.000 description 1
- 235000003406 Polymnia sonchifolia Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 235000021257 carbohydrate digestion Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 229960002840 drug for constipation Drugs 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002605 large molecules Chemical group 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2118—Garcinia cambogia, hydroxycitric acid
Abstract
Description
본 발명은 식이섬유를 함유하는 효소제제로서, 보다 구체적으로는 아밀라아제, 프로테아제 등의 효소의 원천이 되는 효소원 외에 다양한 종류의 식이섬유를 함유하는 효소제제에 관한 것이다.The present invention relates to an enzyme preparation containing dietary fiber, and more particularly, to an enzyme preparation containing various types of dietary fiber in addition to an enzyme source that is a source of enzymes such as amylase and protease.
효소(enzyme)란 생명체 내에서 화학반응의 촉매가 되는 유기화합물로, 동물, 식물 등 모든 생물의 세포는 여러 종류의 효소를 함유하고 있으며, 그러한 효소의 촉매작용에 의하여 생명이 유지된다. 즉 효소는 세포 안에 널리 분포하면서 생명체의 화학적 반응에 관여하는 것이다. 그러한 효소의 기능을 강화시키기 위하여 약제학적으로 제제화된 것이 효소제제로, 원하는 효소활성을 나타내는 물질의 조성물을 나타낸다.An enzyme is an organic compound that catalyzes chemical reactions in living things. The cells of all living things, including animals and plants, contain various types of enzymes, and life is maintained by the catalysis of such enzymes. In other words, enzymes are widely distributed in cells and participate in chemical reactions of living things. In order to enhance the function of such an enzyme, it is an enzyme preparation that is pharmaceutically formulated, and represents a composition of a substance exhibiting a desired enzyme activity.
효소는 인체에 있어서 다양한 생리작용을 수행하는 기능을 가지는바, 대표적으로 소화흡수작용, 혈액정화작용, 항염 및 항균작용, 세포부활작용, 해독/살균작용, 분해/배출작용 등의 기능을 수행한다. 따라서 효소가 부족하면 이러한 생리작용이 원활하게 일어나지 않게 될 수 있다. Enzymes have a function of performing various physiological actions in the human body, and typically perform functions such as digestion and absorption, blood purification, anti-inflammatory and antibacterial action, cell revitalization, detoxification/sterilization, and decomposition/discharge. . Therefore, if the enzyme is insufficient, these physiological actions may not occur smoothly.
예를 들어, 프로테아제가 부족하면 불안감, 수족냉증, 면역기능약화, 신장기능약화, 칼슘흡수 부족, 혈전 생성 등의 증상이 생기고, 아밀라아제가 부족하면 소화장애, 입술염증, 벌레 알레르기, 근육통 등이 발생한다고 한다. 또한 리파아제가 부족하면 위장기능 장애, 담석, 고지혈증, 심혈관질환, 당뇨, 어지럼증 등의 증상이 발생하기도 하며, 다사카리다아제가 부족하면 설사, 변비, 불면증, 우울증 등의 증상이 일어나기 쉽고, 셀룰라아제가 부족하면 복부팽만감, 가스참, 세균감염, 안면통증 등의 증상이 발생한다는 보고도 있다. For example, if there is a lack of protease, symptoms such as anxiety, cold hands and feet, weakened immune function, weakened kidney function, insufficient calcium absorption, and blood clots occur. said to do In addition, if lipase is insufficient, symptoms such as gastrointestinal dysfunction, gallstones, hyperlipidemia, cardiovascular disease, diabetes, and dizziness may occur. There are also reports of symptoms such as bloating, gas, bacterial infection, and facial pain.
건강한 사람에게서는 일반적으로 효소의 분비가 무척 활발하게 일어나 필요할 때마다 적당량의 효소가 적재적소에서 잘 분비되기 때문에 문제가 되지 않으나, 아무리 건강한 사람이라도 나이가 들거나 또는 효소 분비 시스템에 이상이 생기면 효소 생산능력이 떨어지게 된다. 이때는 외부에서 식품이나 영양 보조제의 형태로 효소를 얻는 것이 큰 도움이 된다. 이에 따라 현대사회에서는 복잡해지는 사회구조 속에서 스트레스 등으로 인해 인체 기능이 저하되면서 효소 부족으로 인해 고통받는 사례가 늘고 있으며, 이러한 경우에 도움을 줄 수 있는 외부 효소제제의 필요성이 증대되고 있는 실정이다.In a healthy person, enzyme secretion is generally very active, so it is not a problem because an appropriate amount of enzyme is secreted well in the right place whenever needed. this will fall In this case, it is very helpful to obtain enzymes in the form of food or nutritional supplements from outside. Accordingly, in the modern society, as human body functions deteriorate due to stress in the complex social structure, cases suffering from enzyme deficiency are increasing, and the need for external enzyme preparations that can help in these cases is increasing. .
본 발명은 전술한 바와도 같이 인체에 꼭 필요한 효소를 외부에서 공급해줄 수 있는 효소제제를 제공하고자 하는 것을 목적으로 하고 있으며, 보다 구체적으로는 소화기 계통 질병이나 변비 등을 예방할 수 있는 식이섬유를 추가로 함유하고 간편하게 복용할 수 있는 효소제제를 제공하고자 한다.An object of the present invention is to provide an enzyme preparation that can supply an enzyme essential to the human body from the outside as described above, and more specifically, dietary fiber that can prevent digestive system diseases or constipation is added. We aim to provide an enzyme preparation that contains
본 발명은 상기한 바의 목적을 달성하기 위해, 맥아, 곡자, 식이섬유 성분, 식물성 단백질 등을 함유하는 효소제제를 제공하는 것을 특징적인 구성으로 하고 있다.The present invention has a characteristic configuration to provide an enzyme preparation containing malt, grain, dietary fiber component, vegetable protein, and the like in order to achieve the above object.
본 발명의 일 실시예에 의하면, 식이섬유 성분은 곤약 뿌리 추출분말, 차전차피 추출분말, 난소화성 말토덱스트린 분말, 결정 셀룰로오스, 알로에 분말, 및 가르시니아 캄보지아 분말로부터 선택되는 하나 이상의 성분을 포함하는 것을 특징으로 한다.According to an embodiment of the present invention, the dietary fiber component includes at least one component selected from konjac root extract powder, chamomile extract powder, indigestible maltodextrin powder, crystalline cellulose, aloe powder, and garcinia cambogia powder. characterized.
본 발명의 일 실시예에 의하면 상기 효소제제는 프락토올리고당으로 코팅된 환제인 것을 특징으로 한다.According to an embodiment of the present invention, the enzyme preparation is a pill coated with fructooligosaccharide.
본 발명의 또 다른 실시예에 의하면, 본 발명의 효소제제는 아밀라아제 20,000unit/g 이상, 프로테아제 400unit/g 이상인 것을 특징으로 한다.According to another embodiment of the present invention, the enzyme preparation of the present invention is characterized in that 20,000 units/g of amylase and 400 units/g of protease.
본 발명의 일 실시예에 의하면, 맥아 20~30중량%, 곡자 30~40중량%, 식물혼합분말 20~30중량%, 식물성 단백질 1~5중량%, 팽화미 5~10 중량%, 프락토올리고당 0.05~0.2중량% 포함하는 것을 특징으로 한다.According to an embodiment of the present invention, malt 20-30% by weight, grain 30-40% by weight, plant mixed powder 20-30% by weight, vegetable protein 1-5% by weight, puffed rice 5-10% by weight, fructo It is characterized in that it contains 0.05 to 0.2% by weight of oligosaccharides.
본 발명은 또한 소화대사촉진, 이뇨, 냉증개선, 조혈 및/또는 면역증진을 위한 상기 효소제제를 포함하는 기능성 식품을 제공한다.The present invention also provides a functional food comprising the enzyme preparation for promoting digestion and metabolism, diuresis, improvement of cold, hematopoiesis and/or immunity.
본 발명에 의하면 적절한 소화기능을 촉진하는 효소기능 외에 신진대사촉진 기능을 수행하며, 꾸준히 섭취할 경우 체질개선이 가능한 효소제제 및 기능성 식품을 얻을 수 있다.According to the present invention, it is possible to obtain an enzyme preparation and functional food capable of improving the constitution if it is continuously ingested and performs a metabolism-promoting function in addition to an enzyme function that promotes an appropriate digestive function.
에너지가 없으면 인체 내에서는 아무일도 일어나지 않는다. 이 에너지가 효소때문에 생기기도 하고 없어지기도 한다. 우리몸을 비롯한 모든 생명체의 기본단위인 세포는 화학반응을 통해서 살아간다. 즉 세포는 우리가 섭취하는 탄수화물, 지방, 단백질로부터 에너지를 얻어서 소화, 운동, 공부 등의 일을 하는 것이다. 그런데 세포는 효소의 도움이 없이는 이러한 에너지를 얻을 수 없다는 것이 중요하다. 우리 몸의 신경계를 움직이는 것은 세로토닌, 카테콜아민, 아세틸콜린 등과 같은 여러가지 신경전달 물질이다. 이 신경전달물질은 뇌 속에서 트립토판, 타이로신, 콜린 등의 아미노산을 원료로 하여 만들어진다고 알려져 있으며, 이 과정에서 효소가 매우 중요한 역할을 수행한다. 즉, 우리가 살아가는데 필요한 에너지를 비롯한 다양한 물질의 생산에 효소가 핵심적인 역할을 하는 것이다.Without energy, nothing happens in the human body. This energy is either created or lost due to enzymes. Cells, the basic unit of all living things, including our body, live through chemical reactions. In other words, cells obtain energy from the carbohydrates, fats, and proteins we consume and perform tasks such as digestion, exercise, and study. However, it is important to note that cells cannot obtain this energy without the help of enzymes. Various neurotransmitters such as serotonin, catecholamine, and acetylcholine move the nervous system in our body. It is known that this neurotransmitter is made from amino acids such as tryptophan, tyrosine, and choline in the brain, and enzymes play a very important role in this process. In other words, enzymes play a key role in the production of various substances, including the energy we need to live.
또한 효소는 그 자체로서 인체에서 유용한 기능을 수행하며, 소화흡수작용, 혈액정화작용, 항염 및 항균작용, 세포부활작용, 해독/살균작용, 분해/배출작용 등의 생리작용을 수행하는 것으로 알려져있다.In addition, enzymes themselves perform useful functions in the human body, and are known to perform physiological actions such as digestion and absorption, blood purification, anti-inflammatory and antibacterial actions, cell revitalization, detoxification/sterilization, and decomposition/discharge. .
아밀라아제는 아밀로스와 아밀로펙틴, 다시말해서 녹말을 말토스로 가수분해하는 역할을 하는, 탄수화물 대사의 첫 주자이다. 염소와 칼슘 이온이 들어가 있는 효소로, 타액과 췌장액에서 많이 볼 수 있는 효소이며 α, β, γ의 세 종류가 있다. 아밀라아제가 부족하면 소화장애, 입술 염증, 벌레 알레르기, 근육통 등이 발생한다고 한다. Amylase is the first player in carbohydrate metabolism, responsible for the hydrolysis of amylose and amylopectin, ie, starch to maltose. An enzyme containing chlorine and calcium ions, it is an enzyme found in saliva and pancreatic juice, and there are three types: α, β, and γ. Insufficient amylase can cause digestive problems, inflammation of the lips, insect allergy, and muscle pain.
프로테아제는 단백질이나 펩티드의 펩티드 결합을 가수분해하는 효소의 총칭으로, 단백질 분해효소이다. 폴리펩티드 사슬의 말단에만 작용하여 아미노산 혹은 디펩티드를 차례로 유리시키는 엑소펩티다아제와, 사슬 내부에 작용하여 여러가지 크기의 펩티드를 유리시키는 엔도펩티다아제의 2가지로 나뉜다. 부족하면 불안감, 수족냉증, 면역기능약화, 신장기능약화, 칼슘 흡수 부족, 혈전 생성 등의 증상이 생긴다Protease is a generic term for enzymes that hydrolyze peptide bonds of proteins or peptides, and is a proteolytic enzyme. Exopeptidases, which act only at the ends of polypeptide chains to release amino acids or dipeptides in sequence, and endopeptidases, which act inside the chain to liberate peptides of various sizes. If it is insufficient, symptoms such as anxiety, cold hands and feet, weakened immune function, weakened kidney function, insufficient calcium absorption, and blood clots occur.
본 발명은 상기한 바와 같은 효소를 외부에서 효과적으로 공급할 수 있는 효소제제를 제공하기 위해, 맥아, 곡자, 식이섬유 성분, 식물성 단백질 등을 함유하는 것을 특징으로 한다.The present invention is characterized in that it contains malt, grain, dietary fiber component, vegetable protein, etc. in order to provide an enzyme preparation that can effectively supply the enzyme as described above from the outside.
맥아(麥芽)는 보리에 적당한 온도의 물을 붓고 약 3일간 두어 발아시킨 것으로서, 발아시 아밀라아제의 활성이 강해진다. 보리가 싹이 트려면 보리에 있던 전분질을 분해시켜서 에너지원으로 써야 하므로 보리가 싹이 틀 때에는 전분을 분해시키는 효소인 아밀라아제가 많아진다. 맥아에는 아밀라아제 이외에도 프로테아제, 인버타아제, 산화효소, 피타아제 등이 포함되어 있으며, 맥아 프로테아제는 보리의 단백질을 분해하는 작용을 하기도 한다.Malt (麥芽) is made by pouring water at an appropriate temperature into barley and leaving it for about 3 days to germinate, and the activity of amylase becomes stronger during germination. In order for barley to germinate, the starch in the barley must be decomposed and used as an energy source. In addition to amylase, malt contains proteases, invertases, oxidases, and phytases. Malt proteases also break down proteins in barley.
곡자는 우리나라의 전통 누룩으로서, 우리나라 전통의 발효제이다. 발효에 사용되는 곡물(밀, 보리, 찹쌀, 멥쌀, 녹두, 옥수수, 수수, 기장, 조 등)의 전분을 분해, 당화시켜 포도당으로 만들어주는 효소이자 발효원으로, 알콜 발효의 중요한 원료가 되기도 한다. 곡자는 자연 상태의 누룩곰팡이와 효모균, 젖산균 등이 초재(草材)에서 자연적으로 접종되어 증식된 것을 말한다. 전분을 분해하는 아밀라아제와 단백질을 분해하는 프로테아제를 많이 함유하고 있다.Gokja is a traditional Korean yeast, and it is a traditional Korean fermentation agent. It is an enzyme and fermentation source that decomposes and saccharifies the starch of grains used for fermentation (wheat, barley, glutinous rice, non-glutinous rice, mung bean, corn, sorghum, millet, millet, etc.) . Gokja refers to a product that is naturally inoculated with yeast, lactic acid bacteria, etc. in its natural state and propagated by inoculation. It contains a lot of amylase that breaks down starch and protease that breaks down protein.
본 발명의 식이섬유 성분은 곤약 뿌리 추출분말, 차전차피 추출분말, 난소화성 말토덱스트린 분말, 결정 셀룰로오스, 알로에 분말, 및 가르시니아 캄보지아 분말로부터 선택되는 하나 이상의 성분을 포함하는 것을 특징으로 한다.The dietary fiber component of the present invention is characterized in that it comprises one or more components selected from konjac root extract powder, chamomile extract powder, indigestible maltodextrin powder, crystalline cellulose, aloe powder, and garcinia cambogia powder.
곤약은 글루코만난 4%에 물 96%가 더해진 식품이다. 따라서 곤약 뿌리 추출물은 글루코만난을 다량 포함하며, 글루코만난은 천연 수용성 식이섬유이다. 글루코만난은 만노스와 글루코스가 2:1의 비율로 함유되어 있다. 분자량은 약 100만인 고분자 화합물로 물에 녹아 점성질을 띤 풀 모양이 되고, 알칼리에 의해 물에 녹지 않는 젤리화된 곤약이 된다. 혈액속의 콜레스테롤 값을 낮추는 작용을 하고, 식이섬유로서 장내에서 정장작용을 하여 쾌변을 유도한다.Konjac is a food with 96% water added to 4% glucomannan. Therefore, konjac root extract contains a large amount of glucomannan, which is a natural water-soluble dietary fiber. Glucomannan contains mannose and glucose in a ratio of 2:1. It is a high molecular weight compound with a molecular weight of about 1 million that dissolves in water to form a viscous paste, and becomes jelly-like konjac that does not dissolve in water by alkali. It lowers the cholesterol level in the blood, and as a dietary fiber, it acts as a bowel movement in the intestine to induce pleasant stool.
차전자피는 질경이 씨앗(차전자)의 껍질(피)로, 80% 이상이 식이섬유로 이루어져 있으며 물에 녹는 수용성과 물에 녹지 않는 불용성 식이섬유가 골고루 함유되어 있다. 수용성 식이섬유는 장내 찌꺼기를 흡착하고 대변의 점도를 높여 대변의 이동성을 증가시키는 작용을 하며, 불용성 식이섬유는 수분을 흡수하여 대변의 크기를 늘려주고 대장 통과시간을 단축시켜 변비를 개선한다. 차전자피는 충분한 양의 물을 섭취해야 효과가 나타나며, 몸에 흡수되지 않고 생리현상과 가장 비슷하게 배변을 촉진하여 변비 환자들에게 일차 약물로 추천된다. Psyllium hull is the skin (blood) of plantain seeds (psyllium), and more than 80% of it consists of dietary fiber, and contains both water-soluble and water-insoluble dietary fiber. Soluble fiber absorbs intestinal waste and increases stool viscosity to increase stool mobility, while insoluble fiber absorbs water to increase stool size and shorten colon transit time to improve constipation. Psyllium hull is effective only when a sufficient amount of water is consumed, and it is not absorbed by the body and promotes bowel movements most similar to physiological phenomena, so it is recommended as a first-line drug for constipation patients.
난소화성 말토덱스트린은 수용성 식이섬유의 한 종류이다. 전분에 열을 가하면 열에 의해 열분해가 일어나는데, 이 과정에서 일반적인 탄수화물의 알파 1-4, 1-6 결합 이외에 알파 1-2, 1-3 결합이 생성된다. 사람의 탄수화물 소화효소인 아밀라아제, 아밀로글루코시다아제는 이 알파 1-2, 1-3 결합의 탄수화물을 분해시키지 못한다. 다시말해 체내에서 소화되지 않는 식이섬유로 개질된 것이다. Indigestible maltodextrin is a type of soluble dietary fiber. When heat is applied to starch, thermal decomposition occurs. In this process, alpha 1-2, 1-3 bonds are created in addition to alpha 1-4 and 1-6 bonds of normal carbohydrates. Human carbohydrate digestion enzymes, amylase and amyloglucosidase, cannot break down these alpha 1-2, 1-3 carbohydrates. In other words, it is modified with dietary fiber that cannot be digested by the body.
수용성(물에녹는) 식이섬유 중, 혈당 상승 억제, 장내 유익균 증가의 정장작용, 혈중 지질 저하의 3가지 기능성을 모두 가진 유일한 식이섬유이다. 국내에서 혈당 상승 억제의 기능성을 최초로 식약처로부터 인정받았었다.Among water-soluble (water-soluble) dietary fibers, it is the only dietary fiber that has all three functions: suppressing blood sugar rise, increasing intestinal beneficial bacteria, and lowering blood lipids. In Korea, the function of suppressing blood sugar rise was recognized by the Ministry of Food and Drug Safety for the first time.
알로에 잎의 내부 유조직(parenchyma tissue)은 99% 이상의 물을 함유하며, 다당이 알로에 유조직의 대부분 중량을 차지한다(Grindlay and Reynolds, 1986; Reynolds and Dweck, 1999). 또한, 유조직 중 섬유질은 겔의 약 10%를 차지하여 수분함량 다음가는 대량 함유 성분이다. The inner parenchyma tissue of aloe leaves contains more than 99% water, and polysaccharides make up most of the weight of aloe parenchyma (Grindlay and Reynolds, 1986; Reynolds and Dweck, 1999). In addition, fiber in parenchyma accounts for about 10% of the gel and is the second largest component after moisture content.
알로에 유조직으로부터 추출한 식이섬유는 팽윤력, 보수력 및 지방 흡수능이 공지의 알파-셀룰로오스(α-cellulose) 식이섬유 보다 우수하고, 거품형성능을 나타내지 않아 거품안정성이 높으며, 유화능 및 유화 안정능도 우수하고, CMC 함유 용액은 매우 우수한 분산능을 가지며, 1% 이상의 농도에서 알파-셀룰로오스 보다 높은 농도 의존성 및 의가소성의 점도 특성을 나타내어 새로운 식이섬유 소재로서 유용하게 사용될 수 있고, 포도당 흡수지연 효과와 담즙산 흡수지연효과가 우수하며, 비만 및 변비의 개선 효과를 얻을 수 있다.Dietary fiber extracted from aloe oily tissue is superior to known alpha-cellulose dietary fibers in swelling power, water holding power and fat absorption capacity, and it does not show foaming performance, so it has high foam stability, and has excellent emulsification and emulsification stability. , CMC-containing solution has very good dispersibility and exhibits higher concentration-dependent and pseudoplastic viscosity characteristics than alpha-cellulose at a concentration of 1% or more, so it can be usefully used as a new dietary fiber material, delaying glucose absorption and absorption of bile acids It has an excellent delay effect, and it is possible to obtain the effect of improving obesity and constipation.
가르시니아 캄보지아(Garsinia Canbogia)는 남아시아 서식 나무의 마른과일껍질로부터 추출되는 물질로 HAC(Hydroxy Citric Acid)가 10~30% 함유되어 있다. HAC는 오렌지, 밀감류에 함유된 구연산(Citric acid)과 매우 유사한 물질이나 자연계에서 극히 드물게 발견되며 체내 지방합성 경로를 차단하고 글리코겐의 합성으로 전환시켜 에너지 생산을 증가시킬 뿐만 아니라 식욕을 억제시키고 지방분해를 촉진 시키는 등 다양한 생리활성기능이 있는 것으로 알려져 있다.Garcinia Cambogia is a substance extracted from the dried fruit bark of a tree native to South Asia and contains 10-30% of Hydroxy Citric Acid (HAC). HAC is a substance very similar to citric acid contained in oranges and citrus fruits, but is found extremely rarely in nature. It is known to have various physiologically active functions, such as promoting decomposition.
본 발명의 효소제제는 식물성 단백질을 포함하는데, 바람직하게는 분리대두단백인 것을 특징으로 한다. The enzyme preparation of the present invention is characterized in that it contains a plant protein, and preferably is a soy protein isolate.
본 발명의 효소제제는 추가로 팽화미(彭化米)를 포함할 수 있다. 팽화미는 열과 압력을 가해 부풀린 쌀을 말한다. 팽화에 의해 쌀알이 다공질이 되고 녹말은 덱스트린으로 변하게 된다. The enzyme preparation of the present invention may further include puffed rice (彭化米). Punghwami refers to rice that has been inflated by applying heat and pressure. The rice grains become porous by swelling and the starch turns into dextrin.
본 발명의 효소제제는 다음과 같은 공정을 거쳐 제조될 수 있으나, 이에 제한되는 것은 아니다.The enzyme preparation of the present invention may be prepared through the following process, but is not limited thereto.
1. 우선 질 좋은 맥아를 선별하여 이물질을 가려낸 후 세척한다. 1. First, select high-quality malt, filter out foreign substances, and then wash.
2. 세척이 완료된 맥아를 건조기에 넣고 70~90℃의 온도로 4~5시간 동안 건조시킨다. 2. Put the washed malt in a dryer and dry it at 70~90℃ for 4~5 hours.
3. 건조된 재료는 분쇄기에서 분쇄 후 사별기에서 사별(sieving)한다. 사별되는 입자크기는 100메쉬 전후인 것이 바람직하다. 3. The dried material is pulverized in a pulverizer and then sieved in a sieving machine. It is preferable that the particle size to be separated is around 100 mesh.
4. 사별이 완료된 상기 재료에 분말 형태의 식이섬유 성분, 및 전분을 가해 혼합한 후 물을 부어 연합기를 이용하여 20~40분 정도 연합하여 제립한다. 4. Add and mix the dietary fiber component in powder form and starch to the bereaved material, pour water, and knead for 20 to 40 minutes using a kneader to granulate.
5. 제립된 재료는 장환기를 이용하여 긴 가래떡 모양으로 장환한 후, 이를 적당한 크기로 잘라 일정하게 제환한다. 5. The granulated material is made into a long rice cake shape using a long ventilator, and then cut into an appropriate size and uniformly circulated.
6. 제환된 제품은 열풍건조기를 이용하여 약 50~70℃의 온도로 15시간 전후의 시간동안 건조한다. 6. The recirculated product is dried for about 15 hours at a temperature of about 50~70℃ using a hot air dryer.
7. 건조된 환 제품을 피막제로 코팅한다. 피막제는 올리고당 용액이 바람직하다. 7. Coat the dried pill product with a coating agent. The coating agent is preferably an oligosaccharide solution.
본 발명에 있어서 프락토올리고당이 피막제로 사용될 수 있다. 프락토올리고당은 프리바이오틱스의 한 종류로, 사탕수수에서 추출한 당을 원료로 하기도 하고, 바나나, 야콘, 아스파라거스, 마늘, 양파, 우엉 등 일상에서 섭취하는 다양한 식품 자체에도 들어있다. 장내 유해균 억제, 변비예방과 배변활동 원활, 칼슘흡수 촉진 등의 작용을 나타내며, 단당이 거의 함유되지 않아 당뇨병 환자도 섭취할 수 있는 당질이다.In the present invention, fructooligosaccharide may be used as a coating agent. Fructooligosaccharides are a type of prebiotics, and are made from sugar extracted from sugar cane as a raw material, and are also contained in various foods consumed in daily life, such as bananas, yacon, asparagus, garlic, onions, and burdock root. It suppresses harmful bacteria in the intestine, prevents constipation, facilitates bowel movements, and promotes calcium absorption.
본 발명의 효소제제는 소화를 촉진하는 효소인 아밀라아제와 프로테아제 효소원을 포함함으로써 소화대사 촉진의 효과가 있다. 소화효소의 활성단위인 1unit은 1μmol의 기질을 1μmol의 생산물로 만드는 효소량을 나타내는 것으로서, 예를 들어 아밀라아제 1unit은 전분 180μg을 180μg의 포도당으로 만드는 효소량이다. 본 발명의 효소제제는 아밀라아제 활성 20,000unit/g 이상, 프로테아제 활성 400unit/g 이상인 것을 특징으로 하며, 바람직하게는 아밀라아제 활성 25,000unit/g, 프로테아제 활성 500unit/g이다. The enzyme preparation of the present invention has the effect of promoting digestive metabolism by including amylase and protease enzyme sources that promote digestion. 1 unit, the active unit of digestive enzymes, represents the amount of enzyme that converts 1 μmol of substrate to 1 μmol of product. For example, 1 unit of amylase is the amount of enzyme that converts 180 μg of starch into 180 μg of glucose. The enzyme preparation of the present invention is characterized in that it has an amylase activity of 20,000 units/g or more and a protease activity of 400 units/g or more, and preferably has an amylase activity of 25,000 units/g and a protease activity of 500 units/g.
본 발명의 효소제제는 상기한 효소원 외에 신진대사촉진 기능을 하는 다양한 식물성 약재를 조합하여 포함할 수 있다. 이에 따라 소화대사촉진 효과 이외에도 이뇨, 냉증개선, 조혈, 면역증진 등의 효과를 나타낼 수 있다. 따라서 소화기관 장애를 가진 환자, 면역기능이 약한 사람, 허약체질자, 노약자, 수험생, 직장인 등이 꾸준한 섭취로 인해 체질을 개선할 수 있다는 잇점도 있다.The enzyme preparation of the present invention may include a combination of various plant medicines that have a metabolic promoting function in addition to the above-described enzyme source. Accordingly, in addition to the effect of promoting digestion and metabolism, it can exhibit effects such as diuresis, improvement of poor circulation, hematopoiesis, and immunity enhancement. Therefore, there is an advantage that patients with digestive system disorders, people with weak immune function, the weak constitution, the elderly, examinees, office workers, etc. can improve their constitution through steady intake.
이하에서는 본 발명의 효소제제를 제조하는 구체적인 실시예를 통해 보다 명확하게 본 발명을 설명하고자 하나, 이에 제한되는 것은 아니다.Hereinafter, the present invention will be described more clearly through specific examples for preparing the enzyme preparation of the present invention, but the present invention is not limited thereto.
실시예Example
1. 재료 준비1. Material preparation
맥아 25.2중량%, 곡자 35중량%, 분리대두단백 4중량%, 팽화미 5.9중량%를 준비하였다. Malt 25.2% by weight, grain 35% by weight, isolate soybean protein 4% by weight, and puffed rice 5.9% by weight were prepared.
2. 선별/세척2. Sorting/washing
준비된 재료들로부터 이물질을 골라낸 후 각각 세척하였다.After picking out foreign substances from the prepared materials, each was washed.
3. 건조3. Dry
세척이 완료된 재료들을 건조기에서 80℃로 5시간 동안 건조시켰다.The washed materials were dried in a dryer at 80° C. for 5 hours.
4. 분쇄/사별(seiving)4. Grinding/seving
건조된 재료들을 분쇄기에서 100메쉬로 분쇄한 후 사별기로 사별하였다.The dried materials were pulverized with 100 mesh in a pulverizer, and then separated by a sorter.
5. 연합(제립)5. Union (establishment)
사별이 완료된 재료에 식이섬유 성분 29.8중량%, 및 전분을 가해 혼합한 후 물을 가해 연합기를 이용하여 30분 가량 연합하여 제립화하였다. 식이섬유 성분은 곤약 뿌리 추출 분말 30중량%, 차전차피 분말 20중량%, 난소화성 말토덱스트린 분말 20중량%, 결정 셀룰로오스 10중량%, 알로에 분말 10중량%, 및 가르시니아 캄보지아 분말 10중량%의 비율로 혼합하였다. 29.8 wt% of dietary fiber component, and starch were added to the bereaved material, mixed, and then water was added and kneaded for about 30 minutes using a kneader to granulate. The dietary fiber component is 30% by weight of konjac root extract powder, 20% by weight of chamomile powder, 20% by weight of indigestible maltodextrin powder, 10% by weight of crystalline cellulose, 10% by weight of aloe powder, and 10% by weight of garcinia cambogia powder was mixed with
6. 장환 및 제환6. Janghwan and Jehwan
연합된 재료를 장환기를 이용하여 장환한 후 제환기로 일정하게 제환하였다.The combined materials were circulated using a long ventilator and then uniformly circulated with a ventilator.
7. 건조7. Dry
제환된 제품을 열풍건조기를 이용하여 60℃에서 15시간 가량 건조하였다.The recirculated product was dried at 60°C for about 15 hours using a hot air dryer.
8. 코팅8. Coating
건조된 환제품을 코팅기에 넣고 물에 녹인 20% 프락토올리고당 용액을 피막제로 분부하여 피막을 입혔다.The dried pills were placed in a coating machine, and a 20% fructooligosaccharide solution dissolved in water was sprayed as a coating agent to coat the coating.
9. 검사9. Inspection
피막을 입힌 환제를 선별한 후 식품 규격에 따른 검사를 실시하여 아래와 같은 결과를 얻었다.After screening the coated pills, the test was performed according to food standards, and the following results were obtained.
- 수분 : 10.0% 이하- Moisture: 10.0% or less
- 조단백질 : 10.0% 이상- Crude protein: 10.0% or more
- α아밀라아제 : 25,000unit/g- α-amylase: 25,000unit/g
- 프로테아제 : 500unit/g- Protease : 500unit/g
- 대장균 : 음성-E. coli: negative
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성요소들도 결합된 형태로 실시될 수 있다.The above description of the present invention is for illustration, and those of ordinary skill in the art to which the present invention pertains can understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. For example, each component described as a single type may be implemented in a distributed manner, and likewise components described as distributed may also be implemented in a combined form.
본 발명의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위, 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the following claims rather than the above detailed description, and all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts are interpreted as being included in the scope of the present invention. should be
Claims (5)
상기 식이섬유 성분은 곤약 뿌리 추출분말, 차전차피 추출분말, 난소화성 말토덱스트린 분말, 결정 셀룰로오스, 알로에 분말, 및 가르시니아 캄보지아 분말로부터 선택되는 하나 이상의 성분인 것을 특징으로 하는 효소제제.As an enzyme preparation containing malt, grain, dietary fiber component, and vegetable protein,
The dietary fiber component is an enzyme preparation, characterized in that at least one component selected from konjac root extract powder, chamomile extract powder, indigestible maltodextrin powder, crystalline cellulose, aloe powder, and garcinia cambogia powder.
프락토올리고당으로 코팅된 환제인 것을 특징으로 하는 효소제제.The method of claim 1,
Enzyme preparation, characterized in that the pill is coated with fructooligosaccharide.
팽화미를 추가로 포함하는 것을 특징으로 하는 효소제제.3. The method of claim 2,
Enzyme preparation, characterized in that it further comprises puffed rice.
맥아 20~30중량%, 곡자 30~40중량%, 식이섬유 성분 20~30중량%, 식물성 단백질 1~5중량%, 팽화미 5~10 중량%, 프락토올리고당 0.05~0.2중량% 포함하는 것을 특징으로 하는 효소제제.4. The method of claim 3,
Malt 20-30 wt%, grain 30-40 wt%, dietary fiber component 20-30 wt%, vegetable protein 1-5 wt%, puffed rice 5-10 wt%, fructooligosaccharide 0.05-0.2 wt% Characterized enzyme preparation.
[Claim 5] A functional food comprising the enzyme preparation of any one of claims 1 to 4, for promoting digestion and metabolism, diuresis, improvement of poor circulation, hematopoiesis and/or immunity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200124771A KR20220041492A (en) | 2020-09-25 | 2020-09-25 | Enzyme Preparation comprising Dietary Fiber |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200124771A KR20220041492A (en) | 2020-09-25 | 2020-09-25 | Enzyme Preparation comprising Dietary Fiber |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220041492A true KR20220041492A (en) | 2022-04-01 |
Family
ID=81183347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200124771A KR20220041492A (en) | 2020-09-25 | 2020-09-25 | Enzyme Preparation comprising Dietary Fiber |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20220041492A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102655807B1 (en) * | 2023-12-28 | 2024-04-08 | 복을만드는사람들 주식회사 농업회사법인 | Method for manufacturing tofu low-sugar rice containing indigestible maltodextrin |
-
2020
- 2020-09-25 KR KR1020200124771A patent/KR20220041492A/en not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102655807B1 (en) * | 2023-12-28 | 2024-04-08 | 복을만드는사람들 주식회사 농업회사법인 | Method for manufacturing tofu low-sugar rice containing indigestible maltodextrin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111772071A (en) | Pure plant oat milk and preparation method thereof | |
| WO2016026194A1 (en) | Combined composition of fruits, vegetables and rice flour for food therapy and health care, and preparation method therefor and uses thereof | |
| KR101497050B1 (en) | A manufacturing method of functional fermented food | |
| CN102860519A (en) | Preparation method for reducing hardness of dietary fiber chewable tablets | |
| KR102323416B1 (en) | Manufacturing method for deer horn collagen, deer horn collagen manufactured thereby and composition containing the same | |
| CN106690331A (en) | Kelp dietary fiber granules and preparation method thereof | |
| CN101375727B (en) | Drink containing edible black fungus and ginseng element | |
| KR101611954B1 (en) | A process for the preparation of fermented minerals pills for improving intestine function and fermented minerals pills prepared therefrom | |
| CN106261350A (en) | A kind of sprout brown rice rich in selenium beverage and production technology | |
| KR102014674B1 (en) | Method for producing a cyclic health functional food | |
| KR20070016520A (en) | Health food with powder of astragalus fermented soybeans | |
| CN111184214A (en) | Enzyme collagen coarse cereal, fruit and vegetable instant meal replacement porridge and making method thereof | |
| KR20220041492A (en) | Enzyme Preparation comprising Dietary Fiber | |
| CN105725196A (en) | Blueberry enzyme slice and preparation method thereof | |
| CN108157566A (en) | Lipolysaccharide fruit is got rid of in ferment fruits and vegetables tabletting | |
| CN112655733A (en) | Preparation method of germinated brown rice bread with high GABA content and high protein | |
| KR100965907B1 (en) | Manufacturing method of red ginseng and black ginseng using msm | |
| CN109043275A (en) | Plant enzyme polypeptide decoction pieces and preparation process thereof | |
| CN107212387A (en) | A kind of pectase powder | |
| AU2006233185A1 (en) | Dietary Fibre from Plant Material | |
| CN104161149A (en) | Tartary buckwheat tea containing bitter gourd, pumpkin and cucumber | |
| JP2009034017A (en) | Diet food | |
| CN107432414A (en) | Nourishing rice flour for babies and preparation method thereof | |
| CN1321587C (en) | Snail health product and its preparation method | |
| CN111165534B (en) | Slow-digestion type whole grain energy bar and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |